| DRG-Based Hospital Payment Systems and Technological Innovation in 12 European Countries. | |
| | |
MedLine Citation:
|
PMID: 22152189 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
OBJECTIVES: To assess how diagnosis-related group-based (DRG-based) hospital payment systems in 12 European countries participating in the EuroDRG project pay and incorporate technological innovation. METHODS: A standardized questionnaire was used to guide comprehensive DRG system descriptions. Researchers from each country reviewed relevant materials to complete the questionnaire and drafted standardized country reports. Two characteristics of DRG-based hospital payment systems were identified as particularly important: the existence of short-term payment instruments encouraging technological innovation in different countries, and the characteristics of long-term updating mechanisms that assure technological innovation is ultimately incorporated into DRG-based hospital payment systems. RESULTS: Short-term payment instruments and long-term updating mechanisms differ greatly among the 12 European countries included in this study. Some countries operate generous short-term payment instruments that provide additional payments to hospitals for making use of technological innovation (e.g., France). Other countries update their DRG-based hospital payment systems very frequently and use more recent data for updates. CONCLUSIONS: Generous short-term payment instruments to promote technological innovation should be applied carefully as they may imply rapidly increasing health-care expenditures. In general, they should be granted only if rigorous analyses have demonstrated their benefits. If the evidence remains uncertain, coverage with evidence development frameworks or frequent updates of the DRG-based hospital systems may provide policy alternatives. Once the data and evidence base is substantially improved, future research should empirically investigate how different policy arrangements affect the adoption and use of technological innovation and health-care expenditures. |
| | |
Authors:
|
David Scheller-Kreinsen; Wilm Quentin; Reinhard Busse |
Related Documents
:
|
21900439 - The influence of research compensation options on practice-based research network (pbrn... 21930269 - A conference report on prenatal corticosteroid use in low- and middle-income countries. 21609379 - Should births be centralised in higher level hospitals? experiences from regionalised h... 21615779 - Equine hospital data as a source for study of prevalence and heritability of osteochond... 21584839 - Healthcare consumers' attitudes towards physician and personal use of health informatio... 21994159 - Pediatric hospital medicine: a strategic planning roundtable to chart the future. 8191859 - Twinning rate in the muslim population of west bengal. 21995329 - An intervention to improve care and reduce costs for high-risk patients with frequent h... 20231869 - Human resource and funding constraints for essential surgery in district hospitals in a... |
Publication Detail:
|
Type: Journal Article Date: 2011-09-09 |
Journal Detail:
|
Title: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research Volume: 14 ISSN: 1524-4733 ISO Abbreviation: Value Health Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883818 Medline TA: Value Health Country: United States |
Other Details:
|
Languages: eng Pagination: 1166-72 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Department for Health Care Management, Berlin University of Technology, Berlin, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The national institute for health and clinical excellence single technology appraisal process: lesso...
Next Document: Defining epitope coverage requirements for T cell-based HIV vaccines: Theoretical considerations and...